Citation Impact
Citing Papers
The clinical safety of H1‐receptor antagonists: An EAACI position paper*
1996
The End Of The Beginning: Patient Safety Five Years After ‘To Err Is Human’
2004
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Consensus statement * on the treatment of allergic rhinitis
2000
Proteoglycans in haemopoietic cells
1990
Evaluation of Cetirizine in Patients with Allergic Rhinitis and Perennial Asthma
1996
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma
1995
Non‐cardiac adverse effects of antihistamines (H1‐receptor antagonists)
1999
Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆
1999
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Chemotactic peptides
1988
Cold Urticaria
1977
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
1999
Cetirizine
2004
Efficacy and Safety of Mizolastine in Seasonal Allergic Rhinitis
1996
The human basophil
1990
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Variations among non-sedating antihistamines: are there real differences?
1999
The Pharmacology and Use of H1-Receptor-Antagonist Drugs
1994
Inflammatory Bowel Disease
1991 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Highlights in cardiovascular effects of histamine and HI‐receptor ansgonists
1997
Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial
1995
Neurobiology of Depression
2002 Standout
Cetirizine
1990
Accuracy of Physician Self-assessment Compared With Observed Measures of Competence
2006 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Review of the biology of quercetin and related bioflavonoids
1995 Standout
Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine
1999
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases
2008 StandoutNobel
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge
1995
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis
2000
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
The effect of treatment on IgG, IgA, IgM and α-2-macroglobulin in gingival crevicular fluid from patients with chronic adult periodontitis
1988
Asthma
2000 Standout
Sedation and Performance Issues in the Treatment of Allergic Conditions
1997
Oxidative inactivation of leukotriene C 4 by stimulated human polymorphonuclear leukocytes
1982 StandoutNobel
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Peptide Antimicrobial Agents
2006 Standout
Agents that Release Histamine from Mast Cells
1983
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells.
1985 StandoutNobel
Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.
1983
Mucosal mast cells
1984
The Spectrum of Vasculitis
1978 Standout
Native heparin from rat peritoneal mast cells.
1977
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Prostaglandins and slow-reacting substance
1979
Two Distinct Cellular Patterns In Cutaneous Necrotizing Angitis
1976
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Mast cells and tumor angiogenesis
1976
H1-Receptor Antagonists
1994
The leukotrienes: a new group of biologically active compounds
1981 StandoutNobel
Identification of the slow reacting substances from cat paws.
1980
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
1980 StandoutNobel
Isolation of human eosinophil phospholipase D.
1976
Clinical Presentations And Mechanisms Of Necrotizing Angiitis Of The Skin
1976
Enzymes of the Mast Cell Granule
1980
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
1977
The effect of indomethacin on the contractile response of the guinea‐pig lung parenchymal strip to leukotrienes B4, C4, D4 and E4
1983 StandoutNobel
A Chemotactic Receptor for VAL(ALA)-GLY-SER-GLU on Human Eosinophil Polymorphonuclear Leukocytes
1976
Arachidonic acid metabolism in polymorphonuclear leukocytes
1979 StandoutNobel
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
1981 StandoutNobel
Cytochemical localization of arylsulfatase B in rat basophils and mast cells.
1980
Comparison of the central nervous system effects produce by six H1‐receptor antagonists
1996
Detection of leukotriene A4 as an intermediate in the biosynthesis of leukotrienes C4 and D4
1980 StandoutNobel
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
1979 StandoutNobel
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin
1983 StandoutNobel
Chemical studies on slow reacting substances/leukotrienes
1982 StandoutNobel
Cetirizine in Children with Chronic Allergic Rhinitis
1992
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.
1983 StandoutNobel
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Angiogenic Factors
1987 StandoutScience
Rapid and Sustained Efficacy of Mizolastine 10 mg Once Daily in Seasonal Allergic Rhinitis
1998
Leukotrienes are potent constrictors of human bronchi
1980 StandoutNatureNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile.
1980
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.
1983
Leukotrienes and Slow Reacting Substance of Anaphylaxis (SRS‐A)
1980 StandoutNobel
Leukotrienes: A Novel Group of Biologically Active Compounds
1982 StandoutNobel
Heterogeneity of mammalian mast cells differentiated in vivo and in vitro
1985
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.
1982
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness
1996
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Platelet Activation during Antigen-Induced Airway Reactions in Asthmatic Subjects
1981
Immunologic and Nonimmunologic Generation of Superoxide from Mast Cells and Basophils
1978
Secretory products of macrophages.
1987 Standout
Matrix Metalloproteinases: A Review
1993 Standout
Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds
1981 Nature
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
Slow reacting substances of anaphylaxis: Identification of leukotrienes C-1 and D from human and rat sources
1980
Making it safe: the effects of leader inclusiveness and professional status on psychological safety and improvement efforts in health care teams
2006 Standout
Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.
1987 StandoutNobel
Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis
1975 Nature
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
The patch-clamp technique in the study of secretion
1989 StandoutNobel
Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
1980 Standout
Investigation of the tendency to wheeze in pollen sensitive patients
1992
Works of Wasserman Si being referenced
The release of four mediators of immediate hypersensitivity from human leukemic basophils.
1975
Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis.
1991
31 Evaluation of cetirizine in the treatment of patients with seasonal allergic rhinitis
1988
Release of arylsulfatase A but not B from rat mast cells by noncytolytic secretory stimuli.
1978
Cetirizine therapy for seasonal allergic rhinitis: alternative dosage schedules.
1992
Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A).
1974
Recertification in Internal Medicine: A Program of Continuous Professional Development
2000